ID   WM1158
AC   CVCL_6785
SY   WM-1158; WM 1158; WC00046
DR   cancercelllines; CVCL_6785
DR   Coriell; WC00046
DR   Cosmic; 686407
DR   Cosmic; 888849
DR   Cosmic; 897486
DR   Cosmic; 928686
DR   Cosmic; 1155287
DR   Cosmic; 1507610
DR   Cosmic; 2233684
DR   GEO; GSM185164
DR   GEO; GSM185165
DR   IARC_TP53; 24996
DR   PharmacoDB; WM1158_1667_2019
DR   Progenetix; CVCL_6785
DR   Rockland; WM1158-01-0001
DR   Wikidata; Q54994159
RX   PubMed=11123321;
RX   PubMed=15009714;
WW   https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=15009714; Wistar).
CC   Omics: Transcriptome analysis by microarray.
CC   Discontinued: Coriell; WC00046; probable.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000027.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 12,14
ST   D18S51: 12,13
ST   D19S433: 13,15
ST   D21S11: 31.2,33
ST   D2S1338: 22,25
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 9,13
ST   D8S1179: 10,15
ST   FGA: 21
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 27
//
RX   PubMed=11123321; DOI=10.4049/jimmunol.166.1.432;
RA   Li J., Pereira S., Van Belle P., Tsui P., Elder D.E., Speicher D.W.,
RA   Deen K., Linnenbach A., Somasundaram R., Swoboda R.K., Herlyn D.;
RT   "Isolation of the melanoma-associated antigen p23 using antibody phage
RT   display.";
RL   J. Immunol. 166:432-438(2001).
//
RX   PubMed=15009714; DOI=10.1046/j.0022-202X.2004.22243.x;
RA   Tsao H., Goel V., Wu H., Yang G., Haluska F.G.;
RT   "Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1
RT   inactivation in melanoma.";
RL   J. Invest. Dermatol. 122:337-341(2004).
//